share_log

68% Of This Incyte Insider's Holdings Were Sold

68% Of This Incyte Insider's Holdings Were Sold

这位 Incyte Insider 持有的股份有 68% 被出售
Simply Wall St ·  2023/11/06 08:53

Insiders were net sellers of Incyte Corporation's (NASDAQ:INCY ) stock during the past year. That is, insiders sold more stock than they bought.

内部人士是净卖家 Incyte 公司的 纳斯达克股票代码:INCY)过去一年的股票。也就是说,内部人士卖出的股票多于他们买入的股票。

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

尽管我们认为股东不应简单地关注内幕交易,但我们确实认为密切关注内部人士的所作所为是完全合乎逻辑的。

View our latest analysis for Incyte

查看我们对Incyte的最新分析

The Last 12 Months Of Insider Transactions At Incyte

Incyte 最近 12 个月的内幕交易

Over the last year, we can see that the biggest insider sale was by the Executive VP & Chief Medical Officer, Steven Stein, for US$1.4m worth of shares, at about US$63.28 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The good news is that this large sale was at well above current price of US$54.85. So it may not shed much light on insider confidence at current levels. Steven Stein was the only individual insider to sell shares in the last twelve months.

去年,我们可以看到,执行副总裁兼首席医疗官史蒂芬·斯坦以每股约63.28美元的价格出售了价值140万美元的股票,股价约为63.28美元。虽然我们通常不喜欢看到内幕抛售,但更令人担忧的是销售是否以较低的价格进行。好消息是,这次大甩卖的价格远高于目前的54.85美元。因此,在目前的水平上,它可能无法为内部人士的信心提供太多启示。史蒂芬·斯坦是过去十二个月中唯一一位出售股票的个人内部人士。

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

您可以看到下图所示的去年的内幕交易(公司和个人)。如果你想确切地知道谁卖了,卖了多少钱,什么时候卖了,只需点击下面的图表即可!

insider-trading-volume
NasdaqGS:INCY Insider Trading Volume November 6th 2023
纳斯达克证券交易所:2023年11月6日incy内幕交易量

I will like Incyte better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我看到一些大笔的内幕买入,我会更喜欢Incyte。在我们等着的时候,看看这个 免费的 最近有大量内幕收购的成长型公司名单。

Insider Ownership

内部所有权

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that Incyte insiders own 0.5% of the company, worth about US$64m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

我喜欢看看内部人士在一家公司拥有多少股份,以帮助我了解他们与内部人士的一致性。较高的内部人所有权通常会使公司领导层更加关注股东的利益。看来Incyte内部人士拥有该公司0.5%的股份,价值约6400万美元。当然,我们在其他地方看到了更高的内幕所有权水平,但这些持股足以表明内部人士与其他股东保持一致。

What Might The Insider Transactions At Incyte Tell Us?

Incyte的内幕交易可能会告诉我们什么?

There haven't been any insider transactions in the last three months -- that doesn't mean much. We don't take much encouragement from the transactions by Incyte insiders. But we do like the fact that insiders own a fair chunk of the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted 1 warning sign for Incyte you should know about.

在过去的三个月中,没有任何内幕交易——这并不意味着什么。Incyte内部人士的交易并没有给我们带来太大的鼓舞。但是我们确实喜欢内部人士拥有公司很大一部分股份这一事实。虽然我们喜欢了解内部人士的所有权和交易情况,但在做出任何投资决定之前,我们也一定要考虑股票面临的风险。每家公司都有风险,我们已经发现 Incyte 有 1 个警告标志 你应该知道。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果你想去另一家公司看看 —— 一家财务状况可能优异的公司 —— 那千万不要错过这个 免费的 股本回报率高、债务低的有趣公司名单。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?担心内容吗? 取得联系 直接和我们在一起。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。 我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。 它不构成买入或卖出任何股票的建议,也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。简而言之,华尔街在上述任何股票中都没有头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发